派思股份(603318.SH):大連派思投資有限公司質押及解押1000萬股
格隆匯10月21日丨派思股份(603318.SH)公佈,公司股東大連派思投資有限公司將其持有的公司無限售流通股1000萬股質押給台州紅楓投資合夥企業(有限合夥),此次質押股份佔公司總股本的2.48%,質押登記日為2019年10月16日。2019年10月17日,大連派思投資有限公司將上述股份辦理了解除質押手續。上述質押和解除質押均已辦理完相關手續。
截至本公告披露日,大連派思投資有限公司持有公司股份4755.96萬股(均為無限售條件流通股),佔公司總股本的11.79%,累計股票質押數為3587萬股,佔其持股總數的75.42%,佔公司總股本的8.89%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.